Wilm's tumor: a 10 year retrospective study

Message:
Abstract:
Background
Wilms’ tumor (nephroblastoma) is the most common renal malignancy of childhood. The aim of the study was to evaluate the characteristics of Wilms’ tumor and the results of combined modality treatment obtained in our center in Tehran.
Methods
Fifty-five patients diagnosed as having Wilms’ tumor were studied in the period between February 1992 and March 2002. Demographic features, mode of presentation, associated anomalies, the stage of tumor, histopathologic results, and the survival rates were evaluated.
Results
Of these 55 patients, 31 were males and 24 were females (M/F = 1.2). The mean age at the time of diagnosis was 45.2 months. The distribution of 54 operated patients according to the surgical stage was: stage I 32.7%, stage II 16.36%, stage III 38.1%, stage IV 9%, and stage V 1.8% (one patient (1.8%) has not been operated). Favorable histology was diagnosed in 54.5% and unfavorable histology in 43.6% of the patients. The patients were treated according to National Wilms’ Tumor Study protocols. The relapse-free and overall 4 years survival rates were 71% and 86%, respectively.
Conclusion
As a developing country, with similar relapse free and overall survival rates to National Wilms’ Tumor Study, our institution showed an improvement in the treatment of patients with Wilms’ tumor in recent 10 years, but with more adaptation to the National Wilms’ Tumor Study treatment protocols better optimum results seem to be achievable.
Language:
English
Published:
Archives of Iranian Medicine, Volume:10 Issue: 1, Jan 2007
Page:
65
magiran.com/p594315  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!